Former CEO at Widmann Associates (2004-2013), a corporate advisory firm dedicated to venture capital funds (Vinci Capital/Renaissance, Wellington Partners) and corporations. Patrick developed several investments in the technology and life-sciences sectors, including Actelion, Axovan, Endoart, immatics, Sensimed, Symetis, Evolva and Anergis among others.
In conjunction with the funding, Patrick Scherrer representing Vinci Capital-Renaissance PME, Markus Hosang representing BioMedInvest and Sten Verland representing Sunstone Capital have joined Anergis’ Board of Directors. The Board will be chaired by André J. Mueller, a professional with executive and non-executive experience in biotech ventures.